This inventor holds 4 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Sinew Pharma Inc.. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Hsin-Tien Ho: Innovator in Hepatotoxicity Treatment
Introduction
Hsin-Tien Ho is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical chemistry, particularly in the treatment of hepatotoxicity and fatty liver diseases. With a total of 4 patents, his work focuses on innovative compounds that offer therapeutic benefits.
Latest Patents
Hsin-Tien Ho's latest patents include the development of substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases. These compounds are characterized by a specific structure that includes a C-Calkyl polyol and a saccharide group, which is effective in addressing liver-related health issues. The compounds are represented by a detailed formula, indicating their potential in medical applications.
Career Highlights
Throughout his career, Hsin-Tien Ho has worked with various companies, including Sinew Pharma Inc. and Jacob Biotechnology Ltd. His expertise in the field has allowed him to contribute to advancements in pharmaceutical research and development.
Collaborations
Hsin-Tien Ho has collaborated with notable colleagues such as Oliver Yoa-Pu Hu and Tung-Yuan Shih. These partnerships have further enhanced his research and innovation efforts in the medical field.
Conclusion
Hsin-Tien Ho's work exemplifies the impact of innovative research in treating complex health issues. His contributions to the field of hepatotoxicity treatment highlight the importance of continued innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile